chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Pneumonia, Rhonchi, Sinusitis, Sputum discoloured, Staphylococcal infection
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Staphylococcus test positive, Urine analysis abnormal, VIIth nerve paralysis, Vomiting, Walking aid user
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: White blood cell count increased, White blood cells urine positive, X-ray limb normal
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 37.0
Sex: M
Vaccine: ANTH, FLUN3, MNQ
Symptoms: Activated partial thromboplastin time shortened, Asthenia, Blood creatine phosphokinase increased, Blood phosphorus increased, CSF protein increased
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 37 year old, male patient. Patient's relevant history and concomitant disease were not reported. Patient's vaccine given on same day included anthrax vaccine and meningococcal polysaccharide. Patient received FLUMIST (intranasal) on 18-Sep-2009. It was reported that patient presented with 3 day history of progressive weakness and numbness, rash on the chest shortly after vaccination. Diagnosed with Guillain Barre syndrome on 26-Oct-2009. Also a case of having received attenuated live flu vaccine and anthrax vaccine close in time together. Head CT Normal, CSF protein elevated. Nerve conduction studies-Abnormal. 30-Oct-2009: Labs and diagnostics: LP: CSF Protein 62, UA Negative, ESR 5, MCHC 35.3, Creatine Kinase 174, PTT 26.5, Phosphate 4.6. Head CT-Normal, NCS-Abnormal, Swallow study-Normal. Nerve conduction studies-Abnormal. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of life threatening, hospitalization and patient also required emergency room.
Age: 37.0
Sex: M
Vaccine: ANTH, FLUN3, MNQ
Symptoms: Computerised tomogram head normal, Guillain-Barre syndrome, Hypoaesthesia, Mean cell haemoglobin concentration normal, Nerve conduction studies abnormal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 37 year old, male patient. Patient's relevant history and concomitant disease were not reported. Patient's vaccine given on same day included anthrax vaccine and meningococcal polysaccharide. Patient received FLUMIST (intranasal) on 18-Sep-2009. It was reported that patient presented with 3 day history of progressive weakness and numbness, rash on the chest shortly after vaccination. Diagnosed with Guillain Barre syndrome on 26-Oct-2009. Also a case of having received attenuated live flu vaccine and anthrax vaccine close in time together. Head CT Normal, CSF protein elevated. Nerve conduction studies-Abnormal. 30-Oct-2009: Labs and diagnostics: LP: CSF Protein 62, UA Negative, ESR 5, MCHC 35.3, Creatine Kinase 174, PTT 26.5, Phosphate 4.6. Head CT-Normal, NCS-Abnormal, Swallow study-Normal. Nerve conduction studies-Abnormal. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of life threatening, hospitalization and patient also required emergency room.
Age: 37.0
Sex: M
Vaccine: ANTH, FLUN3, MNQ
Symptoms: Rash, Red blood cell sedimentation rate normal, Urine analysis normal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 37 year old, male patient. Patient's relevant history and concomitant disease were not reported. Patient's vaccine given on same day included anthrax vaccine and meningococcal polysaccharide. Patient received FLUMIST (intranasal) on 18-Sep-2009. It was reported that patient presented with 3 day history of progressive weakness and numbness, rash on the chest shortly after vaccination. Diagnosed with Guillain Barre syndrome on 26-Oct-2009. Also a case of having received attenuated live flu vaccine and anthrax vaccine close in time together. Head CT Normal, CSF protein elevated. Nerve conduction studies-Abnormal. 30-Oct-2009: Labs and diagnostics: LP: CSF Protein 62, UA Negative, ESR 5, MCHC 35.3, Creatine Kinase 174, PTT 26.5, Phosphate 4.6. Head CT-Normal, NCS-Abnormal, Swallow study-Normal. Nerve conduction studies-Abnormal. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of life threatening, hospitalization and patient also required emergency room.
Age: 21.0
Sex: M
Vaccine: FLUN3
Symptoms: Guillain-Barre syndrome
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 21 year old, male patient. The patient's concurrent disease(s) included Wolff-Parkinson-White. Patient had been received FLUMIST (intranasal) started on 08-Nov-2010. The patient experienced Guillain Barre Syndrome which started on 16-Nov-2010. The patient recovered from the event of Guillain Barre Syndrome on an unspecified date. The reporter considered the event Guillain Barre Syndrome to be serious due to hospitalization.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Guillain-Barre syndrome
Clinical narrative: A report from VAERS (Health Authority) concerns a 31 year old male. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 12-Sep-2011 and Unknown H1N1 (intranasal) on an unknown date. He experienced Guillain-Barre syndrome like symptoms. The outcome of the Guillain Barre syndrome was unknown. The reporter considered Guillain Barre syndrome to be serious based on hospitalization.
Age: 14.0
Sex: F
Vaccine: FLUN4
Symptoms: Autopsy, Cerebellar tumour, Death
Clinical narrative: A report from VAERS concerns a 14 year old female. Medical history and concomitant medications were not reported. Patient received nasal FLUMIST QUADRIVALENT. 44 days after vaccination, patient died due to complication of cerebella [sic] vascular tumors. (Death certificate/autopsy report pending). The reporter assessed the event to be serious due to death. Based on the information in this report, and awaiting the reporter's assessment, the company physician considered the event to be at least possibly related to FLUMIST QUADRIVALENT.
Age: 10.0
Sex: M
Vaccine: FLUN4
Symptoms: Asthma, Chest discomfort, Cough, Dyspnoea, Wheezing
Clinical narrative: A report has been received from a Physician concerning a 10 year old, male patient. The patient's concurrent disease(s) included asthma. The patient had a history of asthma since 5 years. The nasal allergies, exercise and illness triggered the asthma attack. On 28-Apr-2011, the patient's BP 98/60, body temperature was 97.8 F, complained of tonsils, adenosis, stiff nose, allergies, dust mites, mold. Given SINGULAIR. On 22-May 2012, the patient's BP 110/84, body temperature was 98.5 F, complained of asthma exacerbation. The patient was given SINGULAIR/ADVAIR/Albuterol. Follow up with pulmonologist. On 08-Apr-2013, the patient's BP was 98/60, body temperature was 97.9 F. On 16-Sep-2014, the patient's BP was 128/64, body temperature was 97.9 F. He was given FLOVENT, NASONEX. He was having dyslexia, explosive stools. Concomitant medications included fluticasone, salmeterol, montelukast, salbutamol and vitamins nos. The patient had been receiving FLUMIST QUADRIVALENT (intranasal) stated on 16-Sep-2014. MD reported that the patient was experiencing an asthmatic reaction after receiving FLUMIST QUADRIVALENT on 16-Sep-2014. Patient had to go to the ER, and a pulmonologist was now following. The other symptoms include difficulty breathing, coughing, chest tightness. The patient went to emergency department of the hospital. The episode was managed by bronchodilators and steroids. The event lasted two days. The symptoms resolved completely. The patient had not received FLUMIST in previous season. The patient had experienced wheezing previously. The patient recovered from the event of asthmatic reaction after receiving FLUMIST QUADRIVALENT on an unspecified date. The reporter considered the case to be non-serious. Laboratory values are available.
Age: 30.0
Sex: M
Vaccine: HEPA
Symptoms: Dysgeusia, Throat tightness
Clinical narrative: Altered taste in mouth. Milky taste in mouth. Tightening of throat after consuming food.
Age: 10.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Redness to the left deltoid and pain at the injection site.
Age: 55.0
Sex: F
Vaccine: VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Pruritus, Rash, Skin lesion, Varicella, Varicella virus test negative
Clinical narrative: Eruption of 3 localized, clustered, itchy skin lesions on low back, resolved over 7 weeks, reoccured 8 weeks later, followed by another cluster on upper back, resolved. MD dx'd varicella lesions from Zostavax vaccine given on 10/15/14.
Age: 55.0
Sex: F
Vaccine: VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Bronchitis, Herpes simplex, Herpes zoster, Rash vesicular, Simplex virus test positive
Clinical narrative: Eruption of 3 localized, clustered, itchy skin lesions on low back, resolved over 7 weeks, reoccured 8 weeks later, followed by another cluster on upper back, resolved. MD dx'd varicella lesions from Zostavax vaccine given on 10/15/14.
Age: 55.0
Sex: F
Vaccine: VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Bronchitis, Herpes simplex, Herpes zoster, Rash pruritic, Rash vesicular
Clinical narrative: Eruption of 3 localized, clustered, itchy skin lesions on low back, resolved over 7 weeks, reoccured 8 weeks later, followed by another cluster on upper back, resolved. MD dx'd varicella lesions from Zostavax vaccine given on 10/15/14.
Age: 55.0
Sex: F
Vaccine: VARZOS, FLUX, VARZOS, FLUX, VARZOS
Symptoms: Skin lesion
Clinical narrative: Eruption of 3 localized, clustered, itchy skin lesions on low back, resolved over 7 weeks, reoccured 8 weeks later, followed by another cluster on upper back, resolved. MD dx'd varicella lesions from Zostavax vaccine given on 10/15/14.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from the Licensed Practical Nurse refers to, two unspecified patients of unknown demographics. On an unknown date, two patients were vaccinated with improperly stored ROTATEQ suspension, 2 ml, oral (strength, lot number was not reported) which was exposed to 76.1F for 32 minutes. No adverse effects were reported. No product quality complaint (PQC) involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Convulsion, Electroencephalogram normal, Lumbar puncture normal, Mental status changes, Stool analysis normal
Clinical narrative: On 1/30, 7 days following MMR, had several episodes of generalized seizures without fever and altered mental status lasting 24 hrs. Comprehensive tox screen negative. Normal EEG.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Toxicologic test normal
Clinical narrative: On 1/30, 7 days following MMR, had several episodes of generalized seizures without fever and altered mental status lasting 24 hrs. Comprehensive tox screen negative. Normal EEG.
Age: 50.0
Sex: F
Vaccine: PNC
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: SEVERE whole-body chills lasting approximately 2.5 hours, followed by mild fever, fatigue, and entire body ache.  This lasted until approximately 48 hours after the injection.
Age: 38.0
Sex: F
Vaccine: FLU3, HEP
Symptoms: Asthenia, Eye irritation, Fatigue, Lacrimation increased
Clinical narrative: Eyes started to burn and tear. Also feeling of fatigue and weakness for weeks following.
Age: 54.0
Sex: M
Vaccine: PNC
Symptoms: Injection site pain, Nuclear magnetic resonance imaging, Pain in extremity
Clinical narrative: Pain in right shoulder radiating to right hand. Continues to be painful and now I am having an MRI and treatment by an orthopedic surgeon.
Age: 52.0
Sex: F
Vaccine: MMR
Symptoms: Acute respiratory distress syndrome, Cough, Dyspnoea, Endotracheal intubation, Immunodeficiency
Clinical narrative: Had measles after MMR vaccine Feb 13th fever to 102 and shortness of breath, 2/16, Admitted to hospital w/bilateral pneumonia, SOB got worse, fever to 101.2 cough, WBC on admission 2.6; Rash onset on 2/18, fever to 103 and rash worsens on 2/19, on 2/20 ARDS, patient was intubated, as of 2/21 patient is stable but no improvement after intubation; 2/23.
Age: 52.0
Sex: F
Vaccine: MMR
Symptoms: Measles post vaccine, Morbillivirus test positive, Pneumonia, Polymerase chain reaction, Pyrexia
Clinical narrative: Had measles after MMR vaccine Feb 13th fever to 102 and shortness of breath, 2/16, Admitted to hospital w/bilateral pneumonia, SOB got worse, fever to 101.2 cough, WBC on admission 2.6; Rash onset on 2/18, fever to 103 and rash worsens on 2/19, on 2/20 ARDS, patient was intubated, as of 2/21 patient is stable but no improvement after intubation; 2/23.
Age: 52.0
Sex: F
Vaccine: MMR
Symptoms: Rash, Treponema test positive, Urine analysis, White blood cell count decreased
Clinical narrative: Had measles after MMR vaccine Feb 13th fever to 102 and shortness of breath, 2/16, Admitted to hospital w/bilateral pneumonia, SOB got worse, fever to 101.2 cough, WBC on admission 2.6; Rash onset on 2/18, fever to 103 and rash worsens on 2/19, on 2/20 ARDS, patient was intubated, as of 2/21 patient is stable but no improvement after intubation; 2/23.
Age: 54.0
Sex: M
Vaccine: FLUX
Symptoms: Bursitis, Drug administered at inappropriate site, Injection site pain, Tendon rupture, Ultrasound scan abnormal
Clinical narrative: Patient was given an influenza vaccine intramuscular left shoulder on 10/8/14. He remembers the injection being given very 'high up' on his arm. He had onset of left shoulder pain within hours. Patient is very clear that there was no prior left shoulder pain or injury prior to this vaccine. Interestingly, 1/3 of all workers at his school given this vaccine developed shoulder pain, and all vaccines were given by the same visiting nurse. The patient was seen by myself as worker's compensation patient for left shoulder pain on 11/13/14 after he was treated by his primary care physician with an intramuscular depo-medrol injection without relief. Diagnosed by myself with subacromial bursitis, given subacromial steroid injection under ultrasound guidance, prescribed physical therapy. 95% pain relief at 4 weeks. Released from care. Within 2 weeks of that he had return of increasing shoulder pain. Seen next by myself on 2/16/15, I ordered MRI due to persistent/recurrent pain. This showed a full thickness non-retracted anterior aspect supraspinatus tendon tear. He has today been referred to an orthopedic surgeon.
Age: 54.0
Sex: M
Vaccine: FLUX
Symptoms: X-ray normal
Clinical narrative: Patient was given an influenza vaccine intramuscular left shoulder on 10/8/14. He remembers the injection being given very 'high up' on his arm. He had onset of left shoulder pain within hours. Patient is very clear that there was no prior left shoulder pain or injury prior to this vaccine. Interestingly, 1/3 of all workers at his school given this vaccine developed shoulder pain, and all vaccines were given by the same visiting nurse. The patient was seen by myself as worker's compensation patient for left shoulder pain on 11/13/14 after he was treated by his primary care physician with an intramuscular depo-medrol injection without relief. Diagnosed by myself with subacromial bursitis, given subacromial steroid injection under ultrasound guidance, prescribed physical therapy. 95% pain relief at 4 weeks. Released from care. Within 2 weeks of that he had return of increasing shoulder pain. Seen next by myself on 2/16/15, I ordered MRI due to persistent/recurrent pain. This showed a full thickness non-retracted anterior aspect supraspinatus tendon tear. He has today been referred to an orthopedic surgeon.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Dyskinesia, Seizure like phenomena, Tremor
Clinical narrative: A SEVERE SHAKING SEIZURE LIKE REACTION.
Age: 19.0
Sex: F
Vaccine: HEP, TYP
Symptoms: Injection site pruritus, Injection site swelling, Peripheral swelling, Pruritus
Clinical narrative: Swelling and itching of hands, feet, and injection site.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Crying, Eye movement disorder, Fear, Joint contracture, Moaning
Clinical narrative: While driving home from clinic mother noted child making groaning noise.  He was in carseat w/ head back, eyes rolled back in head.  His whole body was shaking, legs extended, arms flexed with hands in fist.  This lasted about 3 minutes and then resolved.  For about 1 hour after child was crying, (acting like he was scared) not talking.  After this hour according to mom child seemed normal- ate good evening meal - slept well during the night.  According to mom he has never had a seizure.  He remained in the back seat of the car until mom got home - she did not call any one @ the time, was not seen by anyone.  Mom called the clinic the next morning with this information.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Posture abnormal, Tremor
Clinical narrative: While driving home from clinic mother noted child making groaning noise.  He was in carseat w/ head back, eyes rolled back in head.  His whole body was shaking, legs extended, arms flexed with hands in fist.  This lasted about 3 minutes and then resolved.  For about 1 hour after child was crying, (acting like he was scared) not talking.  After this hour according to mom child seemed normal- ate good evening meal - slept well during the night.  According to mom he has never had a seizure.  He remained in the back seat of the car until mom got home - she did not call any one @ the time, was not seen by anyone.  Mom called the clinic the next morning with this information.
Age: 6.0
Sex: M
Vaccine: IPV, MMR
Symptoms: Rash erythematous, Rash macular, Vaccination site pain, Vaccination site reaction
Clinical narrative: Local rash and soreness around sight of vaccine. Lasted 5 days. Rash was red and splotchy.
Age: 49.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Dyspnoea, Headache, Injection site rash, Oral pain, Pruritus
Clinical narrative: Patient developed a rash at the actual site of injection, that spread to her trunk. Also complained of itching, headache, mouth pain, and some shortness of breath.
Age: 49.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Rash
Clinical narrative: Patient developed a rash at the actual site of injection, that spread to her trunk. Also complained of itching, headache, mouth pain, and some shortness of breath.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Antineutrophil cytoplasmic antibody positive, Asthenia, Biopsy kidney normal, Biopsy lung normal, Chest pain
Clinical narrative: Patient started out with flu-like symptoms starting on the night after the vaccine was administered. Per family, patient never fully returned to baseline state of health. Patient went on to develop chest pain and presented to hospital on 12/27 complaining of chest pain. ACS was ruled out and patient was discharged home the next day with a course of Ceftin for suspected pneumonia. Patient presented to the ED again on 1/22 with complaints of weakness, chills, nausea, dry cough, and increased shortness of breath. Patient was quickly transferred to the MICU with respiratory failure and acute renal failure. Patient was treated for pneumonia but did not respond to antibiotics and all cultures were negative. Patient was subsequently treated for suspected vasculitis based on ANCA studies with cyclophosphamide and methylprednisolone but subsequently expired on 2/23.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Culture negative, Death, Dyspnoea
Clinical narrative: Patient started out with flu-like symptoms starting on the night after the vaccine was administered. Per family, patient never fully returned to baseline state of health. Patient went on to develop chest pain and presented to hospital on 12/27 complaining of chest pain. ACS was ruled out and patient was discharged home the next day with a course of Ceftin for suspected pneumonia. Patient presented to the ED again on 1/22 with complaints of weakness, chills, nausea, dry cough, and increased shortness of breath. Patient was quickly transferred to the MICU with respiratory failure and acute renal failure. Patient was treated for pneumonia but did not respond to antibiotics and all cultures were negative. Patient was subsequently treated for suspected vasculitis based on ANCA studies with cyclophosphamide and methylprednisolone but subsequently expired on 2/23.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Intensive care, Nausea, Pneumonia, Renal failure acute
Clinical narrative: Patient started out with flu-like symptoms starting on the night after the vaccine was administered. Per family, patient never fully returned to baseline state of health. Patient went on to develop chest pain and presented to hospital on 12/27 complaining of chest pain. ACS was ruled out and patient was discharged home the next day with a course of Ceftin for suspected pneumonia. Patient presented to the ED again on 1/22 with complaints of weakness, chills, nausea, dry cough, and increased shortness of breath. Patient was quickly transferred to the MICU with respiratory failure and acute renal failure. Patient was treated for pneumonia but did not respond to antibiotics and all cultures were negative. Patient was subsequently treated for suspected vasculitis based on ANCA studies with cyclophosphamide and methylprednisolone but subsequently expired on 2/23.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Respiratory failure, Vasculitis
Clinical narrative: Patient started out with flu-like symptoms starting on the night after the vaccine was administered. Per family, patient never fully returned to baseline state of health. Patient went on to develop chest pain and presented to hospital on 12/27 complaining of chest pain. ACS was ruled out and patient was discharged home the next day with a course of Ceftin for suspected pneumonia. Patient presented to the ED again on 1/22 with complaints of weakness, chills, nausea, dry cough, and increased shortness of breath. Patient was quickly transferred to the MICU with respiratory failure and acute renal failure. Patient was treated for pneumonia but did not respond to antibiotics and all cultures were negative. Patient was subsequently treated for suspected vasculitis based on ANCA studies with cyclophosphamide and methylprednisolone but subsequently expired on 2/23.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Amenorrhoea, Depressed mood, Polycystic ovaries
Clinical narrative: I stopped getting my periods entirely.  I was put on birth control, which had a terrible effect on my moods and I became depressed. When asking my doctor about the Gardasil shot causing my periods to stop, she said she never heard of that in her life and made me seem like I was crazy. I know it wasn't just a coincidence, it doesn't seem right to me. I had my period perfectly regular my whole life and then as soon as I get the Gardasil shot it stops coming. Doesn't make any sense at all whatsoever.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site pain
Clinical narrative: Noticed a softball size lump at the injection site.  Was painful to the touch.  No other symptoms.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLUN4, HEP, HEPA
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Mother giving child bath at night and notice site was red and swollen, child had complained of pain earlier but mother states all of her children complain of injection pain.  This AM size of redness as increased, swelling decreased.
Age: 3.0
Sex: F
Vaccine: DTAPHEPBIP, HEP, IPV, PNC13
Symptoms: Extra dose administered, Myalgia, Pyrexia
Clinical narrative: CLIENT WAS GIVEN DTAP-POLIO-HEPB VACCINE, POLIO VACCINE, AND HEPB VACCINE IN ONE VISIT. ERROR WAS REPORTED TO MOM AND TO VACCINE ERROR REPORTING PROGRAM. MOM CALLED ON 02/25/15 TO CHECK IN ON CLIENT. MOM STATED CHILD HAD HAD A LOW GRADE FEVER AND MUSCLE SORENESS AFTER VACCINATION AND DENIED ANY COMPLICATIONS RELATED TO VACCINE ADMINISTRATION ERROR.
Age: 68.0
Sex: F
Vaccine: FLUX
Symptoms: Blood test, Grip strength decreased, Hypoaesthesia, Mobility decreased, Musculoskeletal pain
Clinical narrative: Could not raise my arm above my shoulder, extremely painful, hand was numb, could not make a fist with my hand...after 3 week, I went to my Md. he gave me a steroid shot and it relieved alot of the pain, however the hand still goes numb if I hold it up, and I can not sleep on that side of my body, I still have tenderness in the arm and numbness in the hand and lack of strength in the arm and hand.
Age: 68.0
Sex: F
Vaccine: FLUX
Symptoms: Nuclear magnetic resonance imaging, Tenderness, Ultrasound scan
Clinical narrative: Could not raise my arm above my shoulder, extremely painful, hand was numb, could not make a fist with my hand...after 3 week, I went to my Md. he gave me a steroid shot and it relieved alot of the pain, however the hand still goes numb if I hold it up, and I can not sleep on that side of my body, I still have tenderness in the arm and numbness in the hand and lack of strength in the arm and hand.
Age: 19.0
Sex: F
Vaccine: TTOX
Symptoms: Dizziness
Clinical narrative: Donor stated that she had dizziness and was lightheaded while she was at work the day following her recieving the vaccine. She also stated that she waited an about an hour after after getting the vasccine before she started working out. She stated that she is on a low calorie intake diet and dizziness/headaches/lightheadedness have been common for her. Denies nausea/vomiting.
Age: 12.0
Sex: M
Vaccine: MMRV, TDAP
Symptoms: Injection site erythema, Injection site inflammation, Pruritus
Clinical narrative: Tongue itch slight redness site of inj next morning site more inflamed called Health Dept instructed pt to go to urgent care. Pt was treated with Benadryl, Ice sent for provider report.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Arm was swelling at local site of injection. After 2 hours the swelling spread to upper arm on the same side of the injection with itching and redness. Patient took Tylenol and put cold compress at the site of swelling. Patient was informed to also take Benadryl if itching and swelling persists.
Age: 26.0
Sex: F
Vaccine: MENB
Symptoms: Blood culture negative, Chills, Headache, Laboratory test normal, Lumbar puncture normal
Clinical narrative: Around 5:30PM, patient had chills, fever of 100F with headache and neck pain starting around 7PM. Per patient at 12:30 that night, temp was 101.4F and went to ED. Rash noted on lateral right ankle in ED.
Age: 26.0
Sex: F
Vaccine: MENB
Symptoms: Neck pain, Pyrexia, Rash
Clinical narrative: Around 5:30PM, patient had chills, fever of 100F with headache and neck pain starting around 7PM. Per patient at 12:30 that night, temp was 101.4F and went to ED. Rash noted on lateral right ankle in ED.
Sex: M
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event occurred; expired vaccine administered in error.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Autoimmune thyroiditis, Blood thyroid stimulating hormone, Dizziness, Fatigue, Hypothyroidism
Clinical narrative: Dizziness, nausea, fatigue. Got hypothyroid Hashimoto's and POTS shortly after (diagnosed).
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Nausea, Postural orthostatic tachycardia syndrome, Thyroxine free, Tilt table test
Clinical narrative: Dizziness, nausea, fatigue. Got hypothyroid Hashimoto's and POTS shortly after (diagnosed).
Age: 18.0
Sex: M
Vaccine: FLUN3
Symptoms: Abdominal tenderness, Axonal neuropathy, Gait disturbance, Grip strength decreased, Guillain-Barre syndrome
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning an 18 year old, male patient. The patient's concurrent disease(s) included penicillin allergy. The patient had been received nasal FLUMIST started on 29-Aug-2006. The patient experienced Guillain Barre syndrome which started on 30-Aug-2006. Patient admitted to hospital on 02-Sep-2006 with bilateral upper and lower extremity (ascending) weakness, calf pains and intermittent tingling of feet. Vital signs normal, antalgic gait, walks only with assistance. Diagnosed with variant of Guillain Barre, treated with IV Immune Globulin. Remains in hospital, but transferred from ICU to medical ward. Abnormal study electrophysiologic evidence of severe motor greater than sensory acquired multifocal sensorimotor peripheral neuropathy with axonal greater than demyelinating features. Given the history this likely represents GBS. The prognosis for recovery with predominant axonal features would probably be a protracted course. Presented with progressive weakness and numbness in hands and feet time 3 days. Weakness began first then tenderness in his gastrocs and numbness working its way distal to proximal up to his elbow and knees. History of productive cough since beginning of basic training. No fever, chills or night sweats. Exposed to others with diarrhea but he has not had diarrhea. Hospital course continued to have weakness in lower extremities mainly feet, also decreased grip strength with no change during ICU stay. Treated with IVIG for 3 days. No change in neuro symptoms or respiratory function transferred from ICU to medical floor and subsequently discharged. At the time of reporting, the event of Guillain Barre syndrome was ongoing. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Diagnostic test details are available.
Age: 18.0
Sex: M
Vaccine: FLUN3
Symptoms: Hypoaesthesia, Immunoglobulin therapy, Intensive care, Muscular weakness, Nerve conduction studies abnormal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning an 18 year old, male patient. The patient's concurrent disease(s) included penicillin allergy. The patient had been received nasal FLUMIST started on 29-Aug-2006. The patient experienced Guillain Barre syndrome which started on 30-Aug-2006. Patient admitted to hospital on 02-Sep-2006 with bilateral upper and lower extremity (ascending) weakness, calf pains and intermittent tingling of feet. Vital signs normal, antalgic gait, walks only with assistance. Diagnosed with variant of Guillain Barre, treated with IV Immune Globulin. Remains in hospital, but transferred from ICU to medical ward. Abnormal study electrophysiologic evidence of severe motor greater than sensory acquired multifocal sensorimotor peripheral neuropathy with axonal greater than demyelinating features. Given the history this likely represents GBS. The prognosis for recovery with predominant axonal features would probably be a protracted course. Presented with progressive weakness and numbness in hands and feet time 3 days. Weakness began first then tenderness in his gastrocs and numbness working its way distal to proximal up to his elbow and knees. History of productive cough since beginning of basic training. No fever, chills or night sweats. Exposed to others with diarrhea but he has not had diarrhea. Hospital course continued to have weakness in lower extremities mainly feet, also decreased grip strength with no change during ICU stay. Treated with IVIG for 3 days. No change in neuro symptoms or respiratory function transferred from ICU to medical floor and subsequently discharged. At the time of reporting, the event of Guillain Barre syndrome was ongoing. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Diagnostic test details are available.
Age: 18.0
Sex: M
Vaccine: FLUN3
Symptoms: Pain in extremity, Paraesthesia, Peripheral sensorimotor neuropathy, Productive cough
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning an 18 year old, male patient. The patient's concurrent disease(s) included penicillin allergy. The patient had been received nasal FLUMIST started on 29-Aug-2006. The patient experienced Guillain Barre syndrome which started on 30-Aug-2006. Patient admitted to hospital on 02-Sep-2006 with bilateral upper and lower extremity (ascending) weakness, calf pains and intermittent tingling of feet. Vital signs normal, antalgic gait, walks only with assistance. Diagnosed with variant of Guillain Barre, treated with IV Immune Globulin. Remains in hospital, but transferred from ICU to medical ward. Abnormal study electrophysiologic evidence of severe motor greater than sensory acquired multifocal sensorimotor peripheral neuropathy with axonal greater than demyelinating features. Given the history this likely represents GBS. The prognosis for recovery with predominant axonal features would probably be a protracted course. Presented with progressive weakness and numbness in hands and feet time 3 days. Weakness began first then tenderness in his gastrocs and numbness working its way distal to proximal up to his elbow and knees. History of productive cough since beginning of basic training. No fever, chills or night sweats. Exposed to others with diarrhea but he has not had diarrhea. Hospital course continued to have weakness in lower extremities mainly feet, also decreased grip strength with no change during ICU stay. Treated with IVIG for 3 days. No change in neuro symptoms or respiratory function transferred from ICU to medical floor and subsequently discharged. At the time of reporting, the event of Guillain Barre syndrome was ongoing. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Diagnostic test details are available.
Age: 21.0
Sex: M
Vaccine: FLUN3
Symptoms: Areflexia, Asthenia, Ataxia, Back pain, Diplopia
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 21 year old male. The patient's concurrent disease included URI. Patient received FLUMIST (intranasal) on 25-Feb-2009. Patient developed Guillain Barre Syndrome - Miller Fisher Syndrome after multiple vaccinations. Patient had symptoms like Neuropathy, Weakness, Hyporeflexia, Headache, Migraine, Muscle Pain. On 27-Jul-2009 multiple records received including hospital records and follow-up consults. Patient presented with complaints of weakness in legs, lower back pain and stumbling gait as well as diplopia, dysarthria, paresthesias of the fingertips. PE positive for facial nerve paresis, leg weakness, wide-based gait, ataxia with absent DTRs. Treatment with IVIG with partial resolution. Transferred to rehab with continued H/A and back pain. MRI brain positive for sinus thickening. At the time of reporting, the Miller Fisher syndrome and Guillain Barre syndrome were ongoing. The reporter considered the Miller Fisher syndrome and Guillain Barre syndrome to be serious due to hospitalization.
Age: 21.0
Sex: M
Vaccine: FLUN3
Symptoms: Dysarthria, Facial paresis, Gait disturbance, Guillain-Barre syndrome, Headache
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 21 year old male. The patient's concurrent disease included URI. Patient received FLUMIST (intranasal) on 25-Feb-2009. Patient developed Guillain Barre Syndrome - Miller Fisher Syndrome after multiple vaccinations. Patient had symptoms like Neuropathy, Weakness, Hyporeflexia, Headache, Migraine, Muscle Pain. On 27-Jul-2009 multiple records received including hospital records and follow-up consults. Patient presented with complaints of weakness in legs, lower back pain and stumbling gait as well as diplopia, dysarthria, paresthesias of the fingertips. PE positive for facial nerve paresis, leg weakness, wide-based gait, ataxia with absent DTRs. Treatment with IVIG with partial resolution. Transferred to rehab with continued H/A and back pain. MRI brain positive for sinus thickening. At the time of reporting, the Miller Fisher syndrome and Guillain Barre syndrome were ongoing. The reporter considered the Miller Fisher syndrome and Guillain Barre syndrome to be serious due to hospitalization.
Age: 21.0
Sex: M
Vaccine: FLUN3
Symptoms: Hyporeflexia, Immunoglobulin therapy, Migraine, Miller Fisher syndrome, Muscular weakness
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 21 year old male. The patient's concurrent disease included URI. Patient received FLUMIST (intranasal) on 25-Feb-2009. Patient developed Guillain Barre Syndrome - Miller Fisher Syndrome after multiple vaccinations. Patient had symptoms like Neuropathy, Weakness, Hyporeflexia, Headache, Migraine, Muscle Pain. On 27-Jul-2009 multiple records received including hospital records and follow-up consults. Patient presented with complaints of weakness in legs, lower back pain and stumbling gait as well as diplopia, dysarthria, paresthesias of the fingertips. PE positive for facial nerve paresis, leg weakness, wide-based gait, ataxia with absent DTRs. Treatment with IVIG with partial resolution. Transferred to rehab with continued H/A and back pain. MRI brain positive for sinus thickening. At the time of reporting, the Miller Fisher syndrome and Guillain Barre syndrome were ongoing. The reporter considered the Miller Fisher syndrome and Guillain Barre syndrome to be serious due to hospitalization.
Age: 21.0
Sex: M
Vaccine: FLUN3
Symptoms: Myalgia, Neuropathy peripheral, Nuclear magnetic resonance imaging brain abnormal, Paraesthesia, Paresis
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 21 year old male. The patient's concurrent disease included URI. Patient received FLUMIST (intranasal) on 25-Feb-2009. Patient developed Guillain Barre Syndrome - Miller Fisher Syndrome after multiple vaccinations. Patient had symptoms like Neuropathy, Weakness, Hyporeflexia, Headache, Migraine, Muscle Pain. On 27-Jul-2009 multiple records received including hospital records and follow-up consults. Patient presented with complaints of weakness in legs, lower back pain and stumbling gait as well as diplopia, dysarthria, paresthesias of the fingertips. PE positive for facial nerve paresis, leg weakness, wide-based gait, ataxia with absent DTRs. Treatment with IVIG with partial resolution. Transferred to rehab with continued H/A and back pain. MRI brain positive for sinus thickening. At the time of reporting, the Miller Fisher syndrome and Guillain Barre syndrome were ongoing. The reporter considered the Miller Fisher syndrome and Guillain Barre syndrome to be serious due to hospitalization.